Alaunos Therapeutics, Inc.

Bioscience & Disease Healthcare Systems

@AlaunosTx Website LinkedIn Houston, Texas

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer. The company specializes in T-cell receptor (TCR) technology to create personalized therapies that target specific cancer antigens.

Business Information

Target Customers

hospitals oncology clinics research institutions

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model B2B partnerships and collaborations

Pricing Strategy N/A

Sales Channels direct sales, partnerships with healthcare providers

Funding Timeline

Round	Date	Amount	Investors
Series A	Jun 24, 2025	$0.85M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

SEC Filings Digest @USCorpFilings

Jun 26, 2025

$TCRT Equity Offerings: On June 24, 2025, Alaunos Therapeutics, Inc. entered into a subscription agreement to raise $850,000 by selling shares of its Series A-2 Convertible Preferred Stock, priced at $1,000 each, allowing holders a 10% annual dividend and conversion rights into

View on Twitter

Similar Startups

Alpheus Medical

89% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...

Tcelltech

89% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies, particularly a univer...

Altera Biosciences

89% match

Developing universal donor cell therapies that bypass immune rejection.

BioTroy Therapeutics

88% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...